Clinical Characteristics, Prognostic Factors, and Outcomes of Patients With Medullary Thyroid Carcinoma: A Retrospective Review From a Tertiary Care Hospital Cureus
Assessing Thyroid Cancer Risk With GLP-1 Therapy CancerNetwork
The Tell-Tale Sign of Thyroid Cancer Doctors Say You Should Know Prevention
Oncologist explains why women are more likely to get thyroid cancer, shares 5 warning signs: Voice changes, lump in neck | Health Hindustan Times
Surgeons Confront Misaligned Radioactive Iodine Use in Follicular Thyroid Carcinoma The American College of Surgeons
Thyroid cancer ‘atlas’ points to cell types that contribute to disease progression Vanderbilt Health News
From thyroid cancer to 40‑hour fasts: Inside Daymond John’s obsession with biohacking and living longer Fortune
Nation's Largest Thyroid Cancer Center Publishes White Paper Finding No Convincing Evidence That GLP-1 Medications Cause Common Thyroid Cancers PR Newswire
PFAS Thyroid Cancer Lawsuit [2026 Update] robertkinglawfirm.com
Risk factors for postoperative recurrence of differentiated thyroid cancer: a retrospective study Nature
Iowa cancer report finds farmers had fewer cancers compared with the general population KCRG
Genetic insights advance understanding of pediatric thyroid cancer St. Jude Children's Research Hospital
Why are thyroid cancer cases increasing across the world? BBC
At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial) Journal of Nuclear Medicine
A Rare Case of Solitary Brain Metastasis From Papillary Thyroid Carcinoma: The Role of Empiric I-131 Therapy and SPECT/CT (Single Photon Emission Computed Tomography/Computed Tomography) in Achieving an 11-Year Survival Cureus
Overexpressed MET drives aggressive thyroid cancer phenotypes and serves as a precision therapeutic target Nature
Thyroid Disease Linked to PFAS Exposure on Military Bases [2026 Update] robertkinglawfirm.com
Systemic inflammatory indices comprising monocytes provide a clinical significance for thyroid cancer identification Nature
The key m6A methylation regulator IGF2BP1 possesses potential prognostic value in papillary thyroid carcinoma Nature
Epigenetic control in thyroid cancer: mechanisms and clinical perspective Nature
Iowa farmers show 13% fewer cancer cases than expected KTVO
Single status shows age dependent bidirectional effects in differentiated thyroid cancer Nature
Thyroid cancer during pregnancy: Megan’s story Roswell Park Comprehensive Cancer Center
The Medical Minute: The thyroid cancer symptoms you shouldn’t ignore Penn State Health News
NM’s Only Thyroid Cancer Specialty Clinic Expands at UNM SRMC UNM HSC Newsroom
Explainable multimodal deep learning for predicting thyroid cancer lateral lymph node metastasis using ultrasound imaging Nature
Clinical significance of level VII lymph node metastasis in papillary thyroid cancer Nature
Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling Nature
Latest Treatments and Research at MSK To Treat Thyroid Cancer in 2025 Memorial Sloan Kettering Cancer Center
Thyroid cancer in adolescents and young adults: a population-based study in 185 countries worldwide The Lancet
Papillary Thyroid Cancer: Thyroid Lobectomy Provides Comparable Outcomes to Total Thyroidectomy and Radioactive Iodine for Select Patients Memorial Sloan Kettering Cancer Center
If You’re a Woman, You Have Three Times the Risk for Thyroid Cancer Lehigh Valley Health Network
Department of Defense Award Supports CU Thyroid Cancer Research CU Anschutz newsroom
Tumour genetics and thyroid cancer staging: a balancing act The Lancet
Active Surveillance a Safe, Viable Option in Papillary Thyroid Cancer Targeted Oncology
GLP-1RA and thyroid cancer: New study suggests detection bias, not causation Mayo Clinic
Polygenic risk scores in thyroid cancer screening, diagnosis and management Nature
GLP-1 and Thyroid Cancer Link Lacks Evidence, White Paper Finds Targeted Oncology
Brian Schottenheimer reveals he was diagnosed with thyroid cancer at 28 Dallas Cowboys | Official Site of the Dallas Cowboys
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology Business Wire